HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?

Código QR

HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?

Guardado en:

Detalles Bibliográficos
Autor principal:	María-Victoria Mateos
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/12ff639881dc4c38a8675d1d6521e3df
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Daratumumab improves the anti-myeloma effect of newly emerging multidrug therapies
por: Gopalakrishnan S, et al.
Publicado: (2013)

Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
por: Foteini Theodorakakou, et al.
Publicado: (2021)

INSIGHTS INTO DIAGNOSIS AND MANAGEMENT OF ADVANCED MULTIPLE MYELOMA
por: Vasile Musteata, et al.
Publicado: (2021)

Leptomeningeal myelomatosis in previously treated high-risk kappa light chain multiple myeloma: case report and literature review
por: Ohanian M, et al.
Publicado: (2011)

THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
por: Ayşe Uysal, et al.
Publicado: (2021)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
por: Meletios A. Dimopoulos, et al.
Publicado: (2021)

Profile of elotuzumab and its potential in the treatment of multiple myeloma
por: Liu YC, et al.
Publicado: (2014)

CASE REPORT: COEXISTENCE OF CELIAC DISEASE AND MULTIPLE MYELOMA
por: Filiz YAVASOGLU, et al.
Publicado: (2021)

INVESTIGATION OF THE QUALIFICATION OF RADIOLOGICAL TECHNIQUES TO DETECT OSTEOLYTIC LESIONS, FRACTURES, AND OSTEOPOROSIS IN MULTIPLE MYELOMA PATIENTS
por: Atakan Turgutkaya, et al.
Publicado: (2021)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
por: Gupta VA, et al.
Publicado: (2013)

Multiple myeloma: optimal management and long-term disease control
por: Sriskandarajah P, et al.
Publicado: (2014)

CLINICAL PARAMETERS OF MULTIPLE MYELOMA PROGRESSION IN RESIDENTS OF THE GOMEL REGION OF BELARUS
por: Zhanna KOZICH, et al.
Publicado: (2021)

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS
por: Mehmut TURGUT, et al.
Publicado: (2021)

IMPACT OF BONE MARROW FIBROSIS IN MYELOMA PATIENTS UNDERGONE AUTOLOGOUS STEM CELL TRANSPLANTATION
por: Senem Maral, et al.
Publicado: (2021)

A CASE DIAGNOSED WITH FOUR DIFFERENT TUMORS
por: Fatma Tuba YILDIRIM, et al.
Publicado: (2021)

A CASE OF POLYCYTHEMIA DIAGNOSED AS HEMOGLOBIN ANDREW-MINNEAPOLIS
por: Mustafa Bilici, et al.
Publicado: (2021)

Treating the elderly patient with chronic lymphocytic leukemia: current and emerging options
por: Mozaheb Z
Publicado: (2014)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
por: Hans C. Hasselbalch, et al.
Publicado: (2021)

ACQUIRED FACTOR XIII DEFICIENCY WITH RUNX1 MUTATION, A REPORT OF TWO CASES TREATED WITH FACTOR XIII CONCENTRATE
por: Alfadil Haroon, et al.
Publicado: (2021)

MYSTERY OF iAMP
por: Fatma Burçin KURTİPEK, et al.
Publicado: (2021)

SECONDARY CHRONIC MYELOID LEUKEMIA FOLLOWING RADIOACTIVE IODINE (I131)
por: Yousef Hailan, et al.
Publicado: (2021)

T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT
por: Merih Reis Aras, et al.
Publicado: (2021)

THE EVALUATION OF CONGENITAL NEUTROPENIA PATIENTS
por: Nihal Karadaş, et al.
Publicado: (2021)

Preserving fertility in young patients with lymphoma: an overview
por: Patel B, et al.
Publicado: (2014)

Prospective identification of potential factors influencing stem cell mobilization and the necessity for plerixafor use in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation
por: Gopal Krushna Ray, et al.
Publicado: (2021)

CLINICAL AND LABORATORY EVALUATION OF OUR PATIENTS WITH HEREDITARY SPHEROCYTOSIS
por: Senanur Şanlı Çelik, et al.
Publicado: (2021)

THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
por: Fatma YILMAZ, et al.
Publicado: (2021)

EXPERIENCE OF GLASDEGIB IN PATIENTS WITH ELDERLY ACUTE MYELOID LEUKEMIA
por: Nanişe Gizem FENER, et al.
Publicado: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
por: Monarch Shah, et al.
Publicado: (2021)

COMPARISON OF INDIVIDUAL PHARMACOKINETIC DOSING TOOLS IN PATIENTS WITH HEMOPHILIA A
por: Can Alp GENÇ, et al.
Publicado: (2021)

PONATINIB EXPERIENCE IN A PEDIATRIC CHRONIC MYELOID LEUKEMIA PATIENT
por: Serap Karaman, et al.
Publicado: (2021)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
por: Bodiford A, et al.
Publicado: (2015)

Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients
por: Rytting ME
Publicado: (2012)

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
por: Simge ERDEM, et al.
Publicado: (2021)

RETROSPECTIVE EVALUATION OF PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS FOLLOWED IN OUR CLINIC
por: Mehmet Can Ugur, et al.
Publicado: (2021)

PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
por: Seda Şahin, et al.
Publicado: (2021)

ASPARAGINASE INDUCED SINUS VEIN THROMBOSIS IN AN ADULT YOUNG ALL PATIENT
por: Beyza OLUK, et al.
Publicado: (2021)

Reticulocyte Hemoglobin Equivalent: Diagnostic Performance in Assessment of Iron Deficiency in Patients with Hypothyroidism
por: Wardah Aslam, et al.
Publicado: (2021)

THE EFFECT OF COMORBIDITY AND BODY MASS INDEX ON SURVIVAL IN PATIENTS WITH MARGINAL ZONE LYMPHOMA
por: Esra TURAN ERKEK, et al.
Publicado: (2021)

EVALUATION OF THE FREQUENCY OF ARTERIAL AND VENOUS THROMBOSIS AND PREDISPOSING FACTORS IN PATIENTS USING ELTROMBOPAG
por: Derya Deniz Kurekci, et al.
Publicado: (2021)